3Papo T, Andrc MH, Amoura Z, et al. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus. JRheumatol, 1999, 26: 927-930.
4Rcincr AP, Spivak JL. Hemophagocytic histiocytosis: a report of23 new patients and review of the literature. Medicine (Baltimore), 1988, 67: 369-388.
5Risdall R J, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer, 1979, 44: 993-1002.
6Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum, 2003, 49: 633-639.
7Matsumoto Y, Naniwa D, Banno S, et al. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two casc reports. Ther Apher, 1998, 2: 300-304.
8Dalakas MC. Mechanism of action of intravenons immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic disease. Neurology, 1998, 51(Suppl): 2-8.
